About CircuLite
CircuLite is a company based in Teaneck (United States) founded in 2004 was acquired by HeartWare in December 2013. CircuLite has raised $99 million across 8 funding rounds from investors including HHS, HeartWare and Forbion. CircuLite operates in a competitive market with competitors including CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
- Headquarter Teaneck, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CircuLite
CircuLite has successfully raised a total of $99M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $385.8 thousand completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CircuLite
CircuLite has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, HeartWare and Forbion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US and Korea
|
Locked | Locked | Locked |
Investor details for CircuLite
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CircuLite
Investment portfolio details for CircuLite
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CircuLite
Detailed financials for CircuLite
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Circulite Comparisons
Peer comparison for CircuLite
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CircuLite
CircuLite operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Medical devices for heart failure management are developed.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
Detailed competitors of CircuLite
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Circulite
Complete news archive for CircuLite
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CircuLite
CircuLite was founded in 2004 and raised its 1st funding round 3 years after it was founded.
CircuLite is headquartered in Teaneck, United States. It is registered at Teaneck, New Jersey, United States.
Paul J Southworth is the current CEO of CircuLite.
CircuLite is a funded company, having raised a total of $99M across 8 funding rounds to date.
The company was founded in 2004 and is headquartered in Teaneck, United States. Operations focus on the medical device sector, specifically cardiovascular technology. Minimally invasive micro-pumps are produced for long-term partial circulatory support in patients with early-stage heart failure. These devices are implanted using endovascular or minimally invasive surgical methods in a superficial pacemaker-like pocket. The proprietary micro-pump platform supports this compact design for partial support applications.
CircuLite's top competitors include Sequana Medical, CVRx and Adona Medical.
CircuLite has 7 investors. Key investors include HHS, HeartWare, Forbion, Crédit Agricole Private Equity, and Oxford Bioscience Partners.